Drug Profile


Latest Information Update: 26 Jul 2010

Price : $50

At a glance

  • Originator Dr Reddys Laboratories
  • Class
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Type 2 diabetes mellitus

Most Recent Events

  • 08 Aug 2003 Suspended - Preclinical for Type-2 diabetes mellitus in India (unspecified route)
  • 18 Dec 2000 DRF-NPPC is available for licensing (www.drreddys.com)
  • 18 Dec 2000 Preclinical development for Type-2 diabetes mellitus in India (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top